Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australian & New Zealand Urogenital and Prostate Cancer Trials Group Limited (ANZUP)
Scientific Title
Adding mitomycin C to Bacillus of Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle invasive bladder cancer: a randomised phase 3 trial.